Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
Asset Class: Equity
Benchmark: Nifty Pharma TRI
Expense Ratio: 2.53% As on (30-06-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 495.81 Cr As on (30-06-2022)
Turn over: 31.41
NAV as on 08-08-2022

16.509

0.05 (0.3071%)

CAGR Since Inception

7.82%

Nifty Pharma TRI 13.6%

PERFORMANCE of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Scheme Performance (%) Data as on - 08-08-2022

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth -7.48 23.25 14.06 - 7.82
Nifty Pharma TRI -10.15 18.43 7.99 9.55 13.6
Equity: Sectoral-Pharma and Healthcare -9.57 24.7 13.62 14.65 14.53

Yearly Performance (%)

Nav Movement

Fund Managers

Meeta Shetty

Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

RETURNS CALCULATOR for Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Tata India Pharma & Healthcare Fund-Regular Plan-Growth - 0.93 3.67 0.82 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Period
Data as on - 08-08-2022
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -7.48 13.82 23.25 14.06 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -7.33 15.65 29.21 0.0 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 -7.47 13.83 28.76 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -8.87 13.65 26.23 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 -9.57 12.52 24.93 11.15 14.78
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -10.96 10.14 19.32 0.0 0.0
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -10.99 14.05 25.75 17.18 16.22
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -11.43 8.35 21.1 0.0 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -12.07 10.29 23.71 12.1 12.95

PORTFOLIO ANALYSIS of Tata India Pharma & Healthcare Fund-Regular Plan-Growth

Asset Allocation (%)